Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameTildrakizumab Biosimilar - Anti-IL23A mAb - Research Grade
SourceCAS 1326244-10-3
SpeciesHumanized
Molecular weight144kDa
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTildrakizumab,MK-3222, SCH900222,IL23A,anti-IL23A
ReferencePX-TA1309
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Tildrakizumab Biosimilar - Anti-IL23A mAb - Research Grade

General information on Anti-IL23A[Homo sapiens] (Tildrakizumab) Monoclonal Antibody

Tildrakizumab is a humanized IgG1 kappa antibody that targets interleukin 23 p19 with high affinity. It is investigated for the treatment of chronic plaque psoriasis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IL23A recombinant protein
Antigen

Human IL23A recombinant protein

PX-P5123 131$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products